Work

Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial

Year: 2017

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-017-4429-8

Authors: Qamar J. Khan, Bruce F. Kimler, Pavan S. Reddy, Priyanka Sharma, Jennifer R. Klemp, Jennifer L. Nydegger, Hung-Wen Yeh, Carol J. Fabian

Institutions: University of Kansas Medical Center, Cancer Center of Kansas, Laureate Institute for Brain Research

Language: English

Topic: Vitamin D Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, Novartis Pharmaceuticals Corporation, Australian Institute for Musculoskeletal Science, Cancer Center, University of Kansas

OpenAlex ID: W2740739286

FWCI: 2.423

Cites: 25

Cited by: 44

Related to: 10